Imiquimod Cream
Product Images NDC 68462-536

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 68462-536). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn24

Packaging label for Imiquimod Cream USP, 5%, 24 single-use packets, each containing 0.25 g of cream. The label indicates the product is for topical dermatologic use and is a prescription drug by Glenmark Pharmaceuticals Inc., USA. The net weight per box is 6 g. Storage instructions advise keeping the product between 4°C to 25°C, avoiding freezing.*

FDA Label Image

Figure1

A flowchart diagram illustrating the enrollment and treatment outcomes for 209 participants divided into Imiquimod Cream and Vehicle groups. It shows numbers of participants completing treatment, withdrawing, and achieving clear skin status after 16 weeks of treatment and 12 weeks of follow-up in each group.*

FDA Label Image

Logo

FDA Label Image

Structure

Chemical structure of Imiquimod, the active ingredient in the topical cream formulation. The diagram depicts the molecular arrangement of atoms within the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.